{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:38:24Z","timestamp":1773149904646,"version":"3.50.1"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/mop.0b013e328355a3e1","type":"journal-article","created":{"date-parts":[[2012,7,10]],"date-time":"2012-07-10T12:19:08Z","timestamp":1341922748000},"page":"627-631","source":"Crossref","is-referenced-by-count":17,"title":["Clostridium difficile infection and proton pump inhibitors"],"prefix":"10.1097","volume":"24","author":[{"given":"John F.","family":"Pohl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210206","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.disamonth.2009.04.010","article-title":"Clostridium difficile.","volume":"55","author":"McFee","year":"2009","journal-title":"Dis Mon"},{"key":"R2-13-20210206","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.gtc.2006.03.009","article-title":"An update on diagnosis, treatment, and prevention of Clostridium difficile-associated disease.","volume":"35","author":"Aslam","year":"2006","journal-title":"Gastroenterol Clin N Am"},{"key":"R3-13-20210206","first-page":"6114","article-title":"Identification of Clostridium difficile as a cause of pseudomembranous colitis.","volume":"18","author":"George","year":"1978","journal-title":"Br Med J"},{"key":"R4-13-20210206","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10096-011-1292-0","article-title":"Clinical features of Clostridium difficile infection and molecular characterization of the isolated strains in a cohort of Danish hospitalized patients.","volume":"31","author":"Soes","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R5-13-20210206","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2009.02.073","article-title":"Clostridium difficile infection caused by the epidemic BINAP1027 strain.","volume":"136","author":"OConnor","year":"2009","journal-title":"Gastroenterology"},{"key":"R6-13-20210206","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM199401273300406","article-title":"Clostridium difficile colitis.","volume":"330","author":"Kelly","year":"1994","journal-title":"N Engl J Med"},{"key":"R8-13-20210206","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/cid\/cir301","article-title":"Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection.","volume":"53","author":"Stevens","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R10-13-20210206","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1586\/eri.10.95","article-title":"Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients.","volume":"8","author":"Chopra","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R11-13-20210206","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM199401273300406","article-title":"Clostridium difficile infection.","volume":"330","author":"Leclair","year":"1994","journal-title":"N Engl J Med"},{"key":"R12-13-20210206","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1525-1497.2003.20833.x","article-title":"Short-term treatment of gastroesophageal reflux disease.","volume":"18","author":"Van Pinxteren","year":"2003","journal-title":"J Gen Intern Med"},{"key":"R13-13-20210206","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.pa.35.040195.001425","article-title":"The pharmacology of the gastric acid pump: the H, K ATPase.","volume":"35","author":"Sachs","year":"1995","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R14-13-20210206","first-page":"577","article-title":"Acid secretion and the H, K ATPase of the stomach.","volume":"65","author":"Prinz","year":"1992","journal-title":"Yale J Biol Med"},{"key":"R15-13-20210206","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1542\/pir.24-1-12","article-title":"Whats new: proton pump inhibitors and pediatrics.","volume":"24","author":"Patel","year":"2003","journal-title":"Pediatr Rev"},{"key":"R16-13-20210206","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1159\/000331518","article-title":"Acid inhibition and peptic ulcer bleeding.","volume":"29","author":"Stimac","year":"2011","journal-title":"Dig Dis"},{"key":"R17-13-20210206","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cgh.2011.08.012","article-title":"The Zollinger-Ellison syndrome: dangers and consequences of interrupting antisecretory treatment.","volume":"10","author":"Poitras","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R18-13-20210206","first-page":"e228","article-title":"Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting.","volume":"16","author":"Heidelbaugh","year":"2010","journal-title":"Am J Manag Care"},{"key":"R19-13-20210206","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MPG.0b013e31823890b4","article-title":"Proton pump inhibitor use in infants: FDA reviewer experience.","volume":"54","author":"Chen","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R20-13-20210206","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jpeds.2011.08.067","article-title":"Over-prescription of acid-suppression medications in infants: how it came about, why its wrong, and what to do about it.","volume":"160","author":"Hassall","year":"2012","journal-title":"J Pediatr"},{"key":"R21-13-20210206","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MCG.0b013e3182333820","article-title":"Recent safety concerns with proton pump inhibitors.","volume":"46","author":"Chen","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"R22-13-20210206","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1046\/j.1365-2036.2000.00768.x","article-title":"Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.","volume":"14","author":"Laine","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"R23-13-20210206","first-page":"17","article-title":"Proton pump inhibitor-associated pneumonia: not a breath of fresh air at all World J Gastrointest Pharmacol T","volume":"6","author":"Fohl","year":"2011","journal-title":"her"},{"key":"R24-13-20210206","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jamda.2010.12.099","article-title":"Risk factors for aspiration pneumonia in frail older people: a systematic literature review.","volume":"12","author":"Van der Maarel-Wierink C, Vanobbergen","year":"2011","journal-title":"J Am Med Dir Assoc"},{"key":"R25-13-20210206","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/PHM.0b013e3181909b73","article-title":"Examination of selected clinical factors and medication use as risk factors for pneumonia during stroke rehabilitation: a case-control study.","volume":"88","author":"Marciniak","year":"2009","journal-title":"Am J Phys Med Rehabil"},{"key":"R26-13-20210206","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1365-2036.2011.04874.x","article-title":"Systemic review: the use of proton pump inhibitors and increased susceptibility to enteric infection.","volume":"34","author":"Bavishi","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R27-13-20210206","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1572-0241.2007.01275.x","article-title":"Systemic review of the risk of enteric infection in patients taking acid suppression.","volume":"102","author":"Leonard","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R28-13-20210206","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1001\/jama.294.23.2989","article-title":"Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.","volume":"294","author":"Dial","year":"2005","journal-title":"JAMA"},{"key":"R29-13-20210206","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jhm.1901","article-title":"Inappropriate prescribing of proton pump inhibitors in hospitalized patients.","volume":"7","author":"Reid","year":"2012","journal-title":"J Hosp Med"},{"key":"R30-13-20210206","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1503\/cmaj.1040876","article-title":"Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.","volume":"171","author":"Dial","year":"2004","journal-title":"CMAJ"},{"key":"R31-13-20210206","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2036.2006.03015.x","article-title":"Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea.","volume":"24","author":"Yearsley","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R32-13-20210206","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1086\/524320","article-title":"Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients.","volume":"29","author":"Baxter","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R33-13-20210206","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1469-0691.2009.02713.x","article-title":"Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors.","volume":"15","author":"Debast","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"R34-13-20210206","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.suc.2008.09.014","article-title":"Clostridium difficile colitis.","volume":"89","author":"Efron","year":"2009","journal-title":"Surg Clin North Am"},{"key":"R35-13-20210206","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1128\/AAC.01443-06","article-title":"Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C.","volume":"51","author":"Jump","year":"2007","journal-title":"difficile-associated diarrhea Antimicrob Agents Chemother"},{"key":"R36-13-20210206","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3748\/wjg.v16.i2.139","article-title":"Tube feeding, the microbiota, and Clostridium difficile infection.","volume":"16","author":"OKeefe","year":"2010","journal-title":"World J Gastroenterol"},{"key":"R37-13-20210206","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.medcli.2010.12.026","article-title":"Risk factors for Clostridium difficile infections in hospitalized patients.","volume":"137","author":"Monge","year":"2011","journal-title":"Med Clin (Barc)"},{"key":"R38-13-20210206","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1542\/peds.2008-0469","article-title":"Epidemiological features of Clostridium difficile-associated disease among inpatients at childrens hospitals in the United States, 2001-2006.","volume":"122","author":"Kim","year":"2008","journal-title":"Pediatrics"},{"key":"R39-13-20210206","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jpeds.2008.12.039","article-title":"Impact of Clostridium difficile infection on pediatric inflammatory bowel disease.","volume":"154","author":"Pascarella","year":"2009","journal-title":"J Pediatr"},{"key":"R40-13-20210206","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-2036.2009.04229.x","article-title":"Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.","volume":"31","author":"Turco","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"R42-13-20210206","first-page":"134","article-title":"Current treatment options for severe Clostridium difficile-associated disease.","volume":"4","author":"Shen","year":"2008","journal-title":"Gastroenterol Hepatol"},{"key":"R43-13-20210206","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidoxamicin versus vancomycin for Clostridium difficile infection.","volume":"364","author":"Louie","year":"2011","journal-title":"N Engl J Med"},{"key":"R44-13-20210206","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1345\/aph.1M351","article-title":"Fidaxomicin: a macrocyclic antibiotic for the management of Clostridium difficile infection.","volume":"44","author":"Sullivan","year":"2010","journal-title":"Ann Pharmacother"},{"key":"R45-13-20210206","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1093\/jac\/dkr377","article-title":"A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection.","volume":"66","author":"Garey","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"R47-13-20210206","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1745-7599.2011.00617.x","article-title":"Probiotics for prevention of antibiotic-associated diarrhea and Clostridium difficile-associated disease in hospitalized adults: a meta-analysis.","volume":"23","author":"Avadhani","year":"2011","journal-title":"J Am Acad Nurse Pract"},{"key":"R48-13-20210206","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/MCO.0b013e32834fcea8","article-title":"Synbiotics and probiotics in the critically ill after the PROPATRIA trial.","volume":"15","author":"Morrow","year":"2012","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R49-13-20210206","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-3476(05)83393-1","article-title":"Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin.","volume":"118","author":"Leung","year":"1991","journal-title":"J Pediatr"},{"key":"R50-13-20210206","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cgh.2011.08.014","article-title":"Treating Clostridium difficile infection with fecal microbiota transplantation.","volume":"9","author":"Bakken","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R51-13-20210206","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1542\/peds.2009-3363","article-title":"Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol.","volume":"126","author":"Russell","year":"2010","journal-title":"Pediatrics"},{"key":"R52-13-20210206","first-page":"27","article-title":"Prevalence of asymptomatic Clostridium difficile colonization in a nursing home population: a cross-sectional study.","volume":"6","author":"Rivera","year":"2003","journal-title":"J Gend Specif Med"},{"key":"R53-13-20210206","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.amjmed.2010.10.013","article-title":"A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors.","volume":"124","author":"Naggie","year":"2011","journal-title":"Am J Med"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0b013e328355a3e1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:42:19Z","timestamp":1620963739000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201210000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e328355a3e1","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}